Patents by Inventor Mark G. BARRETT

Mark G. BARRETT has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250368745
    Abstract: Provided are antibodies that bind to interleukin-18 binding protein (IL-18BP) and related compositions, which may be used in any of a variety of therapeutic or diagnostic methods, including the treatment or diagnosis of cancers and other diseases.
    Type: Application
    Filed: June 13, 2025
    Publication date: December 4, 2025
    Inventors: Robert A. HORLICK, Helen Toni JUN, Magdalena S. WILLEN, Christine M. CHIDESTER, Mark G. BARRETT, David J. KING, Deborah A. WITHERDEN
  • Patent number: 12365737
    Abstract: Provided are antibodies that bind to interleukin-18 binding protein (IL-18BP) and related compositions, which may be used in any of a variety of therapeutic or diagnostic methods, including the treatment or diagnosis of cancers and other diseases.
    Type: Grant
    Filed: August 27, 2024
    Date of Patent: July 22, 2025
    Assignee: Lassen Therapeutics, Inc.
    Inventors: Robert A. Horlick, Helen Toni Jun, Magdalena S. Willen, Christine M. Chidester, Mark G. Barrett, David J. King, Deborah A. Witherden
  • Publication number: 20240417479
    Abstract: Provided are antibodies that bind to interleukin-18 binding protein (IL-18BP) and related compositions, which may be used in any of a variety of therapeutic or diagnostic methods, including the treatment or diagnosis of cancers and other diseases.
    Type: Application
    Filed: August 27, 2024
    Publication date: December 19, 2024
    Inventors: Robert A. HORLICK, Helen Toni JUN, Magdalena S. WILLEN, Christine M. CHIDESTER, Mark G. BARRETT, David J. KING, Deborah A. WITHERDEN